This company listing is no longer active
iSun Valuation
Is 4U1A undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 4U1A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 4U1A's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 4U1A's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4U1A?
Other financial metrics that can be useful for relative valuation.
What is 4U1A's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$407.98k |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.1x |
Enterprise Value/EBITDA | -2.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 4U1A's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.03x | ||
A62 IGP Advantag | 0.08x | 8.6% | €4.7m |
M8H0 MBH | 0.00003x | n/a | €4.1k |
C0M CCS Abwicklungs | 0.01x | n/a | €1.2m |
CMMIPL CMM Infraprojects | 0.03x | n/a | ₹33.7m |
4U1A iSun | 0.004x | 15.3% | €408.0k |
Price-To-Sales vs Peers: 4U1A is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (0.1x).
Price to Earnings Ratio vs Industry
How does 4U1A's PE Ratio compare vs other companies in the European Construction Industry?
Price-To-Sales vs Industry: 4U1A is good value based on its Price-To-Sales Ratio (0x) compared to the European Construction industry average (0.5x).
Price to Sales Ratio vs Fair Ratio
What is 4U1A's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.004x |
Fair PS Ratio | 0.1x |
Price-To-Sales vs Fair Ratio: 4U1A is good value based on its Price-To-Sales Ratio (0x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | €1.25 0% | 75.5% | €2.58 | €0.47 | n/a | 3 |
May ’25 | €0.16 | €1.25 +703.0% | 75.5% | €2.58 | €0.47 | n/a | 3 |
Apr ’25 | €0.20 | €1.60 +694.3% | 53.5% | €2.52 | €0.46 | n/a | 3 |
Mar ’25 | €0.15 | €1.60 +984.1% | 53.5% | €2.52 | €0.46 | n/a | 3 |
Feb ’25 | €0.18 | €1.60 +767.2% | 53.5% | €2.52 | €0.46 | n/a | 3 |
Jan ’25 | €0.29 | €1.60 +461.0% | 53.5% | €2.52 | €0.46 | n/a | 3 |
Dec ’24 | €0.16 | €1.60 +915.4% | 53.5% | €2.52 | €0.46 | n/a | 3 |
Nov ’24 | €0.17 | €1.76 +961.8% | 37.4% | €2.53 | €0.92 | n/a | 3 |
Oct ’24 | €0.18 | €1.76 +852.7% | 37.4% | €2.53 | €0.92 | n/a | 3 |
Sep ’24 | €0.29 | €1.76 +503.6% | 37.4% | €2.53 | €0.92 | n/a | 3 |
Aug ’24 | €0.39 | €2.22 +468.9% | 12.9% | €2.52 | €1.84 | n/a | 3 |
Jul ’24 | €0.29 | €2.22 +665.1% | 12.9% | €2.52 | €1.84 | n/a | 3 |
Jun ’24 | €0.49 | €2.09 +328.1% | 11.1% | €2.32 | €1.86 | n/a | 2 |
May ’24 | €0.57 | €2.49 +333.4% | 9.1% | €2.72 | €2.27 | €0.16 | 2 |
Jan ’24 | €1.19 | €3.86 +224.3% | 25.0% | €4.82 | €2.89 | €0.29 | 2 |
Dec ’23 | €1.55 | €3.86 +149.0% | 25.0% | €4.82 | €2.89 | €0.16 | 2 |
Aug ’23 | €3.26 | €6.87 +110.7% | 10.3% | €7.58 | €6.16 | €0.39 | 2 |
Jul ’23 | €3.04 | €6.87 +125.9% | 10.3% | €7.58 | €6.16 | €0.29 | 2 |
Jun ’23 | €3.08 | €6.87 +123.0% | 10.3% | €7.58 | €6.16 | €0.49 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.